Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$66.50 – $100.00
57% from low
Exchange
OTC Link
OS
DIASORIN S.R.L.
No one on the platform currently holds DSRLF.
No tracked institution reports a position in DSRLF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-19 | $1.3000 | 2026-05-20 |
| 2025-05-20 | $1.2000 | 2025-05-21 |
| 2024-05-20 | $1.1500 | 2024-05-22 |
No one on the platform has traded DSRLF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.2B | +3.3% | $4.55 | $3.99–$5.11 | 18.8× | 2 |
| 2027 | $1.3B | +6.5% | $5.06 | $4.33–$5.77 | 16.9× | 2 |
| 2028 | $1.4B | +6.1% | $5.59 | $5.48–$5.77 | 15.3× | 1 |
| 2029 | $1.5B | +5.3% | $5.47 | $5.36–$5.64 | 15.6× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $1.12 | $1.71 | +52.7% |
| 2025-03-14 | $2.21 | $0.90 | -59.2% |
| $6.9B |
| — |
| GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $2.34 | +0.00% | $6.2B | — |
| OPHLFOno Pharmaceutical Co., Ltd. | $14.71 | +0.00% | $6.9B | — |
Source: Financial Modeling Prep · peers by sector/industry